Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,378
Sort by:
Europe Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in France, Germany, Italy, Spain, UK-Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 19,700.00
... 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; ... successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate ...
June 2019
1273 pages
Nucleic Acid Testing (NAT) Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in Americas, EMEA, APAC-A 68-Country Analysis-Supplier Shares by Test, Competitive Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 48,500.00
... Typing Genetic Diseases Others Five-year test volume and sales projections for over 30 NAT assays. A comprehensive analysis of the sequencing ... analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers. Extensive review of molecular diagnostic technologies, test ...
June 2019
1850 pages
